Class of 2023
Scientific Area of Expertise: Cancer Vaccines, Chronic Lymphocytic Leukemia, Immunogenomics
For groundbreaking discoveries involving immunogenic antigen targets; for developing genomic-guided immunotherapy and neoantigen-targeting cancer vaccines; and for translating these research findings into early-phase clinical trials designed to ascertain the clinical viability of personalized tumor vaccines in melanoma and glioblastoma patients.